A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations.
Conclusion: ctDNA monitoring can be used for early detection of non-response in patients without targetable mutations, and therefore could supplement imaging data for treatment monitoring in this subset of patients.
PMID: 30123427 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Genetics | Lung Cancer | Non-Small Cell Lung Cancer